New gel could keep your nose clear longer

NCT ID NCT07582328

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a gel form of the common decongestant oxymetazoline (found in many nasal sprays) in 120 healthy adults with a stuffy nose from colds or allergies. The gel is designed to stay in the nose longer than a spray. Researchers measured how well a single dose relieved congestion over two hours and checked for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
oxymetazoline hydrochloride 0.05% nasal gel
What this could lead to
If it works, this gel could offer longer-lasting relief from a stuffy nose compared to standard sprays.
What could go wrong
This is a small, early-phase trial. The gel may not work better than placebo, and side effects like nasal irritation are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASAL CONGESTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Nasal Obstruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cliantha Research

    Mississauga, Ontario, L4W, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.